NO20042380L - Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider - Google Patents

Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider

Info

Publication number
NO20042380L
NO20042380L NO20042380A NO20042380A NO20042380L NO 20042380 L NO20042380 L NO 20042380L NO 20042380 A NO20042380 A NO 20042380A NO 20042380 A NO20042380 A NO 20042380A NO 20042380 L NO20042380 L NO 20042380L
Authority
NO
Norway
Prior art keywords
polypeptides
factor
pharmaceutical preparation
factor vii
vii polypeptides
Prior art date
Application number
NO20042380A
Other languages
English (en)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of NO20042380L publication Critical patent/NO20042380L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20042380A 2001-11-09 2004-06-08 Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider NO20042380L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101660 2001-11-09
PCT/DK2002/000736 WO2003039584A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Publications (1)

Publication Number Publication Date
NO20042380L true NO20042380L (no) 2004-06-08

Family

ID=8160820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042380A NO20042380L (no) 2001-11-09 2004-06-08 Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider

Country Status (16)

Country Link
EP (1) EP1446149A1 (no)
JP (1) JP2005511599A (no)
KR (1) KR20050043734A (no)
CN (1) CN1596125A (no)
AU (1) AU2002340779B2 (no)
BR (1) BR0213953A (no)
CA (1) CA2464615A1 (no)
CZ (1) CZ2004543A3 (no)
HU (1) HUP0401985A3 (no)
IL (1) IL161544A0 (no)
MX (1) MXPA04004304A (no)
NO (1) NO20042380L (no)
PL (1) PL370634A1 (no)
RU (1) RU2004117534A (no)
WO (1) WO2003039584A1 (no)
ZA (1) ZA200403271B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378249A1 (en) 1999-07-14 2001-01-25 Mirella Ezban Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
ATE547519T1 (de) 2003-09-09 2012-03-15 Novo Nordisk Healthcare Ag Gerinnungsfaktor-vii-polypeptide
JP2007520531A (ja) * 2004-02-05 2007-07-26 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 外傷の治療のための、ＶＩＩａ因子の使用
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
WO2007104317A1 (en) * 2006-03-16 2007-09-20 Drugrecure Aps Methods for local treatment with factor vii
BR112016009954A2 (pt) * 2013-11-04 2017-12-05 Univ California terapia para o tratamento ou prevenção de condições associadas a sangramento hipocoagulação

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE200225T1 (de) * 1994-04-22 2001-04-15 Sanquin Bloedvoorziening Mittel für die behandlung von störungen des blutgerinnungsprozess
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
JP2002514433A (ja) * 1998-05-14 2002-05-21 バッテル メモリアル インスティテュート トランスジェニック植物由来ヒト凝血因子

Also Published As

Publication number Publication date
CN1596125A (zh) 2005-03-16
EP1446149A1 (en) 2004-08-18
PL370634A1 (en) 2005-05-30
HUP0401985A2 (hu) 2004-12-28
BR0213953A (pt) 2004-08-31
AU2002340779B2 (en) 2007-08-02
CA2464615A1 (en) 2003-05-15
MXPA04004304A (es) 2004-08-11
ZA200403271B (en) 2004-11-08
RU2004117534A (ru) 2005-05-10
JP2005511599A (ja) 2005-04-28
CZ2004543A3 (cs) 2004-08-18
HUP0401985A3 (en) 2009-03-30
IL161544A0 (en) 2004-09-27
KR20050043734A (ko) 2005-05-11
WO2003039584A1 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20033143D0 (no) Farmasoytisk preparat
NO20033556D0 (no) Farmasöytiske preparater
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
HUP0500989A2 (en) Animicrobial polypeptides and their uses
EE200300416A (et) Ravimvorm
DK200300344U1 (da) Amlodipinmaleat og farmaceutisk præparat indeholdende amlodipinmaleat
NO20034159L (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
IS7089A (is) Lyfjasamsetningar amlódipíns og atórvastatíns
NO20035627D0 (no) Farmasöytisk formulering
NO20035315D0 (no) Farmasöytiske kombinasjoner
NO20025805L (no) Farmasöytisk preparat
NO20040235L (no) Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider
IL159872A0 (en) Gmg-2 polypeptides and their use
EP1462455A4 (en) NOVEL PEPTIDES AND THEIR USES AS MEDICAMENTS
NO20042693L (no) Kateterpreparat og anvendelser derav
NO20023144D0 (no) Kompleks omfattende OCIF og polysakkarid
NO20042380L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider
NO20042379L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider
NO20015534D0 (no) Farmasöytisk blandeapparat
NO20021036L (no) Farmasöytisk preparat
DE60219418T8 (de) Silanylphenole und -naphthole
DK200100256U3 (da) Amlodipinmaleat og farmaceutiske præparater indeholdende dette
NO20041236L (no) Farmasoytisk formulering

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application